中华皮肤科杂志 ›› 2024, Vol. 57 ›› Issue (2): 109-118.doi: 10.35541/cjd.20230371
中国“一带一路”皮肤病专病联盟分枝杆菌病研究联盟 中国麻风防治协会皮肤性病检验与诊断分会
收稿日期:2023-06-27
修回日期:2023-10-10
发布日期:2024-02-01
通讯作者:
王洪生
E-mail:whs33@vip.sina.com
Mycobacteriosis Research Group, China " Belt and Road " Dermatology Alliance; Division of Dermatology and STI Diagnosis, Chinese Association on Leprosy
Received:2023-06-27
Revised:2023-10-10
Published:2024-02-01
Contact:
Wang Hongsheng
E-mail:whs33@vip.sina.com
摘要： 【摘要】 非结核分枝杆菌系指除结核分枝杆菌复合群和麻风分枝杆菌以外的其他分枝杆菌。近年来，非结核分枝杆菌引起的皮肤及软组织感染的发病率呈增长趋势，但因其临床表现缺乏特异性，容易误诊。本共识旨在提升我国临床医生对该病的认识，规范疾病诊治行为。
中国“一带一路”皮肤病专病联盟分枝杆菌病研究联盟 中国麻风防治协会皮肤性病检验与诊断分会. 中国皮肤非结核分枝杆菌病诊治专家共识（2024版）[J]. 中华皮肤科杂志, 2024,57(2):109-118. doi:10.35541/cjd.20230371
Mycobacteriosis Research Group, China " Belt and Road " Dermatology Alliance, Division of Dermatology and STI Diagnosis, Chinese Association on Leprosy. Expert consensus on the diagnosis and treatment of cutaneous nontuberculous mycobacterial diseases in China （2024）[J]. Chinese Journal of Dermatology, 2024, 57(2): 109-118.doi:10.35541/cjd.20230371
| ［1］ | Kumar K, Loebinger MR. Nontuberculous mycobacterial pulmonary disease: clinical epidemiologic features, risk factors, and diagnosis: the nontuberculous mycobacterial series［J］. Chest, 2022,161（3）:637⁃646. doi: 10.1016/j.chest. 2021.10.003. |
| ［2］ | Wagner D, Young LS. Nontuberculous mycobacterial infections: a clinical review［J］. Infection, 2004,32（5）:257⁃270. doi: 10. 1007/s15010⁃004⁃4001⁃4. |
| ［3］ | Johansen MD, Herrmann JL, Kremer L. Non⁃tuberculous mycobacteria and the rise of Mycobacterium abscessus［J］. Nat Rev Microbiol, 2020,18（7）:392⁃407. doi: 10.1038/s41579⁃020⁃0331⁃1. |
| ［4］ | Falkinham JO 3rd. Nontuberculous mycobacteria in the environment［J］. Clin Chest Med, 2002,23（3）:529⁃551. doi: 10. 1016/s0272⁃5231（02）00014⁃x. |
| ［5］ | 王洪生, 吴勤学. 皮肤非结核分枝杆菌病［J］. 临床皮肤科杂志, 2006,35（8）:548⁃550. doi: 10.3969/j.issn.1000⁃4963.2006. 08.039. |
| ［6］ | Lamb RC, Dawn G. Cutaneous non⁃tuberculous mycobacterial infections［J］. Int J Dermatol, 2014,53（10）:1197⁃1204. doi: 10. 1111/ijd.12528. |
| ［7］ | Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline［J］. Eur Respir J, 2020,56（1）:2000535. doi: 10.1183/13993003.00535⁃2020. |
| ［8］ | 中华医学会结核病学分会, 《中华结核和呼吸杂志》编辑委员会. 非结核分枝杆菌病诊断与治疗专家共识［J］. 中华结核和呼吸杂志, 2012,35（8）:572⁃580. doi: 10.3760/cma.j.issn.1001⁃0939.2012.08.006. |
| ［9］ | Forbes BA, Hall GS, Miller MB, et al. Practical guidance for clinical microbiology laboratories: mycobacteria［J］. Clin Microbiol Rev, 2018,31（2）:e00038⁃00017. doi: 10.1128/CMR. 00038⁃17. |
| ［10］ | Tortoli E, Fedrizzi T, Meehan CJ, et al. The new phylogeny of the genus Mycobacterium: the old and the news［J］. Infect Genet Evol, 2017,56:19⁃25. doi: 10.1016/j.meegid.2017.10.013. |
| ［11］ | van Ingen J, Turenne CY, Tortoli E, et al. A definition of the Mycobacterium avium complex for taxonomical and clinical purposes, a review［J］. Int J Syst Evol Microbiol, 2018,68（11）:3666⁃3677. doi: 10.1099/ijsem.0.003026. |
| ［12］ | Jiang H, Sun J, Chen Y, et al. Landscape of the genome and host cell response of Mycobacterium shigaense reveals pathogenic features［J］. Emerg Microbes Infect, 2018,7（1）:112. doi: 10. 1038/s41426⁃018⁃0116⁃z. |
| ［13］ | Mei YM, Zhang Q, Zhang WY, et al. Isolation of novel Mycobacterium species from skin infection in an immunocompromised person［J］. Emerg Infect Dis, 2021,27（11）:2944⁃2947. doi: 10.3201//eid2711.210426. |
| ［14］ | Gopinath K, Singh S. Non⁃tuberculous mycobacteria in TB⁃endemic countries: are we neglecting the danger?［J/OL］. PLoS Negl Trop Dis, 2010,4（4）:e615. doi: 10.1371/journal.pntd.0000615. |
| ［15］ | To K, Cao R, Yegiazaryan A, et al. General overview of nontuberculous mycobacteria opportunistic pathogens: Mycobacterium avium and Mycobacterium abscessus［J］. J Clin Med, 2020,9（8）:2541. doi: 10.3390/jcm9082541. |
| ［16］ | Wentworth AB, Drage LA, Wengenack NL, et al. Increased incidence of cutaneous nontuberculous mycobacterial infection, 1980 to 2009: a population⁃based study［J］. Mayo Clin Proc, 2013,88（1）:38⁃45. doi: 10.1016/j.mayocp.2012.06.029. |
| ［17］ | Chen HY, Chen CY, Huang CT, et al. Skin and soft⁃tissue infection caused by non⁃tuberculous mycobacteria in Taiwan, 1997 -2008［J］. Epidemiol Infect, 2011,139（1）:121⁃129. doi: 10.1017/S0950268810001603. |
| ［18］ | Mei Y, Zhang W, Shi Y, et al. Cutaneous tuberculosis and nontuberculous mycobacterial infections at a national specialized hospital in China［J］. Acta Derm Venereol, 2019,99（11）:997⁃1003. doi: 10.2340/00015555⁃3283. |
| ［19］ | 中华医学会结核病学分会. 非结核分枝杆菌病诊断与治疗指南（2020年版）［J］. 中华结核和呼吸杂志, 2020,43（11）:918⁃946. doi: 10.3760/cma.j.cn112147⁃20200508⁃00570. |
| ［20］ | 全国第五次结核病流行病学抽样调查技术指导组,全国第五次结核病流行病学抽样调查办公室. 2010年全国第五次结核病流行病学抽样调查报告［J］. 中国防痨杂志, 2012,34（8）:485⁃508. |
| ［21］ | Chirasuthat P, Triyangkulsri K, Rutnin S, et al. Cutaneous nontuberculous mycobacterial infection in Thailand: a 7⁃year retrospective review［J］. Medicine （Baltimore）, 2020,99（10）:e19355. doi: 10.1097/MD.0000000000019355. |
| ［22］ | Griffith DE, Aksamit T, Brown⁃Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases［J］. Am J Respir Crit Care Med, 2007,175（4）:367⁃416. doi: 10.1164/rccm.200604⁃571ST. |
| ［23］ | Sander MA, Isaac⁃Renton JL, Tyrrell GJ. Cutaneous nontuberculous mycobacterial infections in Alberta, Canada: an epidemiologic study and review［J］. J Cutan Med Surg, 2018,22（5）:479⁃483. doi: 10.1177/1203475418776945. |
| ［24］ | Abbas O, Marrouch N, Kattar MM, et al. Cutaneous non⁃tuberculous mycobacterial infections: a clinical and histo⁃pathological study of 17 cases from Lebanon［J］. J Eur Acad Dermatol Venereol, 2011,25（1）:33⁃42. doi: 10.1111/j.1468⁃3083.2010.03684.x. |
| ［25］ | Yeo PM, Lee SX, Tan YE, et al. Epidemiology, risk factors, and outcomes of adult cutaneous non⁃tuberculous mycobacterial infection over a 10⁃year period in Singapore［J］. Int J Dermatol, 2019,58（6）:679⁃687. doi: 10.1111/ijd.14356. |
| ［26］ | Yacisin K, Hsieh JL, Weiss D, et al. Outbreak of non⁃tuberculous mycobacteria skin or soft tissue infections associated with handling fish ⁃ New York City, 2013-2014［J］. Epidemiol Infect, 2017,145（11）:2269⁃2279. doi: 10.1017/S0950268817001066. |
| ［27］ | Franco⁃Paredes C, Marcos LA, Henao⁃Martínez AF, et al. Cutaneous mycobacterial infections［J］. Clin Microbiol Rev, 2018,32（1）:e00069⁃00018. doi: 10.1128/CMR.00069⁃18. |
| ［28］ | Henkle E, Winthrop KL. Nontuberculous mycobacteria infections in immunosuppressed hosts［J］. Clin Chest Med, 2015,36（1）:91⁃99. doi: 10.1016/j.ccm.2014.11.002. |
| ［29］ | Kendall BA, Winthrop KL. Update on the epidemiology of pulmonary nontuberculous mycobacterial infections［J］. Semin Respir Crit Care Med, 2013,34（1）:87⁃94. doi: 10.1055/s⁃0033⁃1333567. |
| ［30］ | Gonzalez⁃Santiago TM, Drage LA. Nontuberculous mycobacteria: skin and soft tissue infections［J］. Dermatol Clin, 2015,33（3）:563⁃577. doi: 10.1016/j.det.2015.03.017. |
| ［31］ | Bartralot R, García⁃Patos V, Sitjas D, et al. Clinical patterns of cutaneous nontuberculous mycobacterial infections［J］. Br J Dermatol, 2005,152（4）:727⁃734. doi: 10.1111/j.1365⁃2133.2005. 06519.x. |
| ［32］ | Johnson MG, Stout JE. Twenty⁃eight cases of Mycobacterium marinum infection: retrospective case series and literature review［J］. Infection, 2015,43（6）:655⁃662. doi: 10.1007/s15010⁃015⁃0776⁃8. |
| ［33］ | Su Q, Wang F. Painful nodules on the arms［J］. N Engl J Med, 2021,384（11）:e41. doi: 10.1056/NEJMicm2028530. |
| ［34］ | Aubry A, Chosidow O, Caumes E, et al. Sixty⁃three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates［J］. Arch Intern Med, 2002,162（15）:1746⁃1752. doi: 10.1001/archinte.162.15. 1746. |
| ［35］ | Feng Y, Xu H, Wang H, et al. Outbreak of a cutaneous Mycobacterium marinum infection in Jiangsu Haian, China［J］. Diagn Microbiol Infect Dis, 2011,71（3）:267⁃272. doi: 10.1016/j.diagmicrobio.2011.07.003. |
| ［36］ | Ang P, Rattana⁃Apiromyakij N, Goh CL. Retrospective study of Mycobacterium marinum skin infections［J］. Int J Dermatol, 2000,39（5）:343⁃347. doi: 10.1046/j.1365⁃4362.2000.00916.x. |
| ［37］ | Jernigan JA, Farr BM. Incubation period and sources of exposure for cutaneous Mycobacterium marinum infection: case report and review of the literature［J］. Clin Infect Dis, 2000,31（2）:439⁃443. doi: 10.1086/313972. |
| ［38］ | 牛理达, 吕聪聪, 潘搏, 等. 游泳池肉芽肿2例［J］. 临床皮肤科杂志, 2021,50（7）:429⁃432. doi: 10.16761/j.cnki.1000⁃4963. 2021.07.015. |
| ［39］ | Holmes GF, Harrington SM, Romagnoli MJ, et al. Recurrent, disseminated Mycobacterium marinum infection caused by the same genotypically defined strain in an immunocompromised patient［J］. J Clin Microbiol, 1999,37（9）:3059⁃3061. doi: 10. 1128/JCM.37.9.3059⁃3061.1999. |
| ［40］ | Lindeboom JA, Bruijnesteijn van Coppenraet LE, van Soolingen D, et al. Clinical manifestations, diagnosis, and treatment of Mycobacterium haemophilum infections［J］. Clin Microbiol Rev, 2011,24（4）:701⁃717. doi: 10.1128/CMR.00020⁃11. |
| ［41］ | 陈浩, 符美华, 许昌春, 等. 皮肤嗜血分枝杆菌感染二例研究［J］. 中华皮肤科杂志, 2015,48（10）:679⁃682. doi: 10.3760/cma.j.issn.0412⁃4030.2015.10.003. |
| ［42］ | Busam KJ, Kiehn TE, Salob SP, et al. Histologic reactions to cutaneous infections by Mycobacterium haemophilum［J］. Am J Surg Pathol, 1999,23（11）:1379⁃1385. doi: 10.1097/00000478⁃199911000⁃00008. |
| ［43］ | Gao W, Chen H, Wang H, et al. Bilateral sporotrichoid cutaneous infection by Mycobacterium haemophilum in a Chinese patient with systemic lupus erythematosus［J］. Acta Derm Venereol, 2015,95（6）:760⁃761. doi: 10.2340/00015555⁃2076. |
| ［44］ | Smith S, Taylor GD, Fanning EA. Chronic cutaneous Mycobacterium haemophilum infection acquired from coral injury［J］. Clin Infect Dis, 2003,37（7）:e100⁃e101. doi: 10.1086/377267. |
| ［45］ | Zhang M, Feng M, He JQ. Disseminated Mycobacterium kansasii infection with cutaneous lesions in an immuno⁃competent patient［J］. Int J Infect Dis, 2017,62:59⁃63. doi: 10.1016/j.ijid.2017. 07.006. |
| ［46］ | Sopoh GE, Johnson RC, Chauty A, et al. Buruli ulcer surveillance, Benin, 2003-2005［J］. Emerg Infect Dis, 2007,13（9）:1374⁃1376. doi: 10.3201/eid1309.061338. |
| ［47］ | Debacker M, Aguiar J, Steunou C, et al. Mycobacterium ulcerans disease （Buruli ulcer） in rural hospital, Southern Benin, 1997-2001［J］. Emerg Infect Dis, 2004,10（8）:1391⁃1398. doi: 10.3201/ eid1008.030886. |
| ［48］ | Amofah G, Bonsu F, Tetteh C, et al. Buruli ulcer in Ghana: results of a national case search［J］. Emerg Infect Dis, 2002,8（2）:167⁃170. doi: 10.3201/eid0802.010119. |
| ［49］ | Silva MT, Portaels F, Pedrosa J. Aquatic insects and Mycobacterium ulcerans: an association relevant to Buruli ulcer control?［J/OL］. PLoS Med, 2007,4（2）:e63. doi: 10.1371/journal.pmed.0040063. |
| ［50］ | Chung J, Ince D, Ford BA, et al. Cutaneous infections due to nontuberculosis mycobacterium: recognition and management［J］. Am J Clin Dermatol, 2018,19（6）:867⁃878. doi: 10.1007/s40257⁃018⁃0382⁃5. |
| ［51］ | Hospers IC, Wiersma IC, Dijkstra PU, et al. Distribution of Buruli ulcer lesions over body surface area in a large case series in Ghana: uncovering clues for mode of transmission［J］. Trans R Soc Trop Med Hyg, 2005,99（3）:196⁃201. doi: 10.1016/j.trstmh.2004.05.004. |
| ［52］ | Pszolla N, Sarkar MR, Strecker W, et al. Buruli ulcer: a systemic disease［J］. Clin Infect Dis, 2003,37（6）:e78⁃82. doi: 10.1086/377170. |
| ［53］ | WHO. Buruli ulcer （Mycobacterium ulcerans infection）［M］. 2022. |
| ［54］ | Hojat L, Tobolowsky F, Franco⁃Paredes C. Cutaneous Manifestations of Mycobacterium kansasii Infection［J］. Curr Trop Med Rep, 2018,5（4）:224⁃227. doi: 10.1007/s40475⁃018⁃0160⁃8. |
| ［55］ | Czelusta A, Moore AY. Cutaneous Mycobacterium kansasii infection in a patient with systemic lupus erythematosus: case report and review［J］. J Am Acad Dermatol, 1999,40（2 Pt 2）:359⁃363. doi: 10.1016/s0190⁃9622（99）70486⁃x. |
| ［56］ | Stengem J, Grande KK, Hsu S. Localized primary cutaneous Mycobacterium kansasii infection in an immunocompromised patient［J］. J Am Acad Dermatol, 1999,41（5 Pt 2）:854⁃856. doi: 10.1016/s0190⁃9622（99）70344⁃0. |
| ［57］ | Mougari F, Guglielmetti L, Raskine L, et al. Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment［J］. Expert Rev Anti Infect Ther, 2016,14（12）:1139⁃1154. doi: 10.1080/14787210.2016.1238304. |
| ［58］ | 李丹, 王羽, 林威, 等. 美容术后并发非结核分枝杆菌感染治疗策略［J］. 中国医疗美容, 2022,12（7）:24⁃28. doi: 10.19593/j.issn.2095⁃0721.2022.07.007. |
| ［59］ | 周桂文, 徐潇, 杨亦, 等. 自体脂肪移植隆乳后非结核分枝杆菌感染的救治策略［J］. 中国美容医学, 2022,31（9）:1⁃4. |
| ［60］ | 雷朝勇, 李兴, 吴福山, 等. 假体隆乳术后脓肿分枝杆菌感染一例［J］. 中华整形外科杂志, 2021,37（11）:1271⁃1275. doi: 10.3760/cma.j.cn114453⁃20210226⁃00085. |
| ［61］ | Kothavade RJ, Dhurat RS, Mishra SN, et al. Clinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteria［J］. Eur J Clin Microbiol Infect Dis, 2013,32（2）:161⁃188. doi: 10.1007/s10096⁃012⁃1766⁃8. |
| ［62］ | Zhang X, Liu W, Liu W, et al. Cutaneous infections caused by rapidly growing mycobacteria: case reports and review of clinical and laboratory aspects［J］. Acta Derm Venereol, 2015,95（8）:985⁃989. doi: 10.2340/00015555⁃2105. |
| ［63］ | 余敏, 廖桂秀, 纪明开. 美容注射术后皮肤脓肿分枝杆菌感染临床分析［J］. 中国麻风皮肤病杂志, 2022,38（1）:37⁃38. doi: 10.12144/zgmfskin202201037. |
| ［64］ | Wang SH, Pancholi P. Mycobacterial skin and soft tissue infection［J］. Curr Infect Dis Rep, 2014,16（11）:438. doi: 10. 1007/s11908⁃014⁃0438⁃5. |
| ［65］ | Tokunaga DS, Siu AM, Lim SY. Nontuberculous mycobacterial skin and soft tissue infection in Hawai′i［J］. BMC Infect Dis, 2022,22（1）:360. doi: 10.1186/s12879⁃022⁃07345⁃y. |
| ［66］ | Winthrop KL, Abrams M, Yakrus M, et al. An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon［J］. N Engl J Med, 2002,346（18）:1366⁃1371. doi: 10. 1056/NEJMoa012643. |
| ［67］ | Wilson JW, Jagtiani AC, Wengenack NL. Mycobacterium scrofulaceum disease: experience from a tertiary medical centre and review of the literature［J］. Infect Dis （Lond）, 2019,51（8）:602⁃609. doi: 10.1080/23744235.2019.1634281. |
| ［68］ | Sanders JW, Walsh AD, Snider RL, et al. Disseminated Mycobacterium scrofulaceum infection: a potentially treatable complication of AIDS［J］. Clin Infect Dis, 1995,20（3）:549. doi: 10.1093/clinids/20.3.549. |
| ［69］ | Takemoto Y, Tokuyasu H, Ikeuchi T, et al. Disseminated Mycobacterium scrofulaceum infection in an immunocompetent host［J］. Intern Med, 2017,56（14）:1931⁃1935. doi: 10.2169/internalmedicine.56.8181. |
| ［70］ | Chen Y, Jiang J, Jiang H, et al. Mycobacterium gordonae in patient with facial ulcers, nosebleeds, and positive T⁃SPOT.TB test, China［J］. Emerg Infect Dis, 2017,23（7）:1204⁃1206. doi: 10.3201/eid2307.162033. |
| ［71］ | Gao W, Chen H, Jiang H, et al. Disseminated cutaneous infection caused by Mycobacterium colombiense［J］. Acta Derm Venereol, 2014,94（6）:727⁃728. doi: 10.2340/00015555⁃1828. |
| ［72］ | Inagaki Y, Ito T, Kato T, et al. Disseminated cutaneous infection of Mycobacterium colombiense in a patient with myelodysplastic syndrome［J］. Intern Med, 2018,57（3）:423⁃427. doi: 10.2169/internalmedicine.7890⁃16. |
| ［73］ | Sun X, Zhang T, Sun H, et al. Disseminated nontuberculous mycobacterial infection with cryptic immunodeficiency mimicking malignancy: a case report［J］. BMC Pulm Med, 2022,22（1）:452. doi: 10.1186/s12890⁃022⁃02227⁃0. |
| ［74］ | Xie B, Chen Y, Wang J, et al. Mycobacterium marseillense infection in human skin, China, 2018［J］. Emerg Infect Dis, 2019,25（10）:1991⁃1993. doi: 10.3201/eid2510.190695. |
| ［75］ | Cui P, Vissa V, Li W, et al. Cutaneous Mycobacterium shigaense infection in immunocompetent woman, China［J］. Emerg Infect Dis, 2013,19（5）:819⁃820. doi: 10.3201/eid1905.121022. |
| ［76］ | Koizumi Y, Shimizu K, Shigeta M, et al. Mycobacterium shigaense causes lymph node and cutaneous lesions as immune reconstitution syndrome in an AIDS patient: the third case report of a novel strain non⁃tuberculous mycobacterium［J］. Intern Med, 2016,55（22）:3375⁃3381. doi: 10.2169/internalmedicine.55.6996. |
| ［77］ | Phillips R, Horsfield C, Mangan J, et al. Cytokine mRNA expression in Mycobacterium ulcerans⁃infected human skin and correlation with local inflammatory response［J］. Infect Immun, 2006,74（5）:2917⁃2924. doi: 10.1128/IAI.74.5.2917⁃2924.2006. |
| ［78］ | Santa Cruz DJ, Strayer DS. The histologic spectrum of the cutaneous mycobacterioses［J］. Hum Pathol, 1982,13（5）:485⁃495. doi: 10.1016/s0046⁃8177（82）80032⁃4. |
| ［79］ | Bartralot R, Pujol RM, García⁃Patos V, et al. Cutaneous infections due to nontuberculous mycobacteria: histopathological review of 28 cases. Comparative study between lesions observed in immunosuppressed patients and normal hosts［J］. J Cutan Pathol, 2000,27（3）:124⁃129. doi: 10.1034/j.1600⁃0560.2000. 027003124.x. |
| ［80］ | Kromer C, Fabri M, Schlapbach C, et al. Diagnosis of mycobacterial skin infections［J］. J Dtsch Dermatol Ges, 2019,17（9）:889⁃893. doi: 10.1111/ddg.13925. |
| ［81］ | 中华医学会结核病学分会, 非结核分枝杆菌病实验室诊断专家共识编写组. 非结核分枝杆菌病实验室诊断专家共识［J］. 中华结核和呼吸杂志, 2016,39（6）:438⁃443. doi: 10.3760/cma.j.issn.1001⁃0939.2016.06.007. |
| ［82］ | van Ingen J. Diagnosis of nontuberculous mycobacterial infections［J］. Semin Respir Crit Care Med, 2013,34（1）:103⁃109. doi: 10.1055/s⁃0033⁃1333569. |
| ［83］ | Yotsu RR, Murase C, Sugawara M, et al. Revisiting Buruli ulcer［J］. J Dermatol, 2015,42（11）:1033⁃1041. doi: 10.1111/1346⁃8138.13049. |
| ［84］ | Haworth CS, Banks J, Capstick T, et al. British Thoracic Society guidelines for the management of non⁃tuberculous mycobacterial pulmonary disease （NTM⁃PD）［J］. Thorax, 2017,72（Suppl 2）:ii1⁃ii64. doi: 10.1136/thoraxjnl⁃2017⁃210927. |
| ［85］ | 黄海荣. 非结核分枝杆菌相关实验室检查及其结果解读［J］. 中华结核和呼吸杂志, 2020,43（11）:910⁃913. doi: 10.3760/cma.j.cn112147⁃20200316⁃00346. |
| ［86］ | Gopalaswamy R, Shanmugam S, Mondal R, et al. Of tuberculosis and non⁃tuberculous mycobacterial infections ⁃ a comparative analysis of epidemiology, diagnosis and treatment［J］. J Biomed Sci, 2020,27（1）:74. doi: 10.1186/s12929⁃020⁃00667⁃6. |
| ［87］ | Pao CC, Yen TS, You JB, et al. Detection and identification of Mycobacterium tuberculosis by DNA amplification［J］. J Clin Microbiol, 1990,28（9）:1877⁃1880. doi: 10.1128/jcm.28.9.1877⁃1880.1990. |
| ［88］ | Huang H, Deng J, Qin C, et al. Disseminated coinfection by Mycobacterium fortuitum and Talaromyces marneffei in a non⁃HIV case［J］. Infect Drug Resist, 2021,14:3619⁃3625. doi: 10.2147/IDR.S316881. |
| ［89］ | Miao Q, Ma Y, Wang Q, et al. Microbiological diagnostic performance of metagenomic next⁃generation sequencing when applied to clinical practice［J］. Clin Infect Dis, 2018,67（suppl_2）:S231⁃S240. doi: 10.1093/cid/ciy693. |
| ［90］ | Fangous MS, Mougari F, Gouriou S, et al. Classification algorithm for subspecies identification within the Mycobacterium abscessus species, based on matrix⁃assisted laser desorption ionization⁃time of flight mass spectrometry［J］. J Clin Microbiol, 2014,52（9）:3362⁃3369. doi: 10.1128/JCM.00788⁃14. |
| ［91］ | Rodríguez⁃Sánchez B, Ruiz⁃Serrano MJ, Marín M, et al. Evaluation of matrix⁃assisted laser desorption ionization⁃time of flight mass spectrometry for identification of nontuberculous mycobacteria from clinical isolates［J］. J Clin Microbiol, 2015,53（8）:2737⁃2740. doi: 10.1128/JCM.01380⁃15. |
| ［92］ | Chen Y, Jiang H, Zhang W, et al. Diagnostic value of T⁃SPOT.TB test in cutaneous mycobacterial infections［J］. Acta Derm Venereol, 2018,98（10）:989⁃990. doi: 10.2340/00015555⁃3011. |
| ［93］ | Brown⁃Elliott BA, Nash KA, Wallace RJ Jr. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria［J］. Clin Microbiol Rev, 2012,25（3）:545⁃582. doi: 10.1128/CMR.05030⁃11. |
| ［94］ | Nash KA, Zhang Y, Brown⁃Elliott BA, et al. Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum［J］. J Antimicrob Chemother, 2005,55（2）:170⁃177. doi: 10.1093/jac/dkh523. |
| ［95］ | Aubry A, Jarlier V, Escolano S, et al. Antibiotic susceptibility pattern of Mycobacterium marinum［J］. Antimicrob Agents Chemother, 2000,44（11）:3133⁃3136. doi: 10.1128/AAC.44.11. 3133⁃3136.2000. |
| ［96］ | Dorronsoro I, Sarasqueta R, González AI, et al. Cutaneous infections by Mycobacterium marinum. Description of 3 cases and review of the literature［J］. Enferm Infecc Microbiol Clin, 1997,15（2）:82⁃84. |
| ［97］ | Flondell M, Ornstein K, Björkman A. Invasive Mycobacterium marinum infection of the hand［J］. J Plast Surg Hand Surg, 2013,47（6）:532⁃534. doi: 10.3109/2000656X.2013.779801. |
| ［98］ | Rallis E, Koumantaki⁃Mathioudaki E. Treatment of Mycobacterium marinum cutaneous infections［J］. Expert Opin Pharmacother, 2007,8（17）:2965⁃2978. doi: 10.1517/14656566. 8.17.2965. |
| ［99］ | Hisamichi K, Hiruma M, Yamazaki M, et al. Efficacy of oral minocycline and hyperthermic treatment in a case of atypical mycobacterial skin infection by Mycobacterium marinum［J］. J Dermatol, 2002,29（12）:810⁃811. doi: 10.1111/j.1346⁃8138.2002. tb00228.x. |
| ［100］ | Lee CN, Lee JY. Local hyperthermia therapy for refractory cutaneous Mycobacterium marinum infection［J］. Dermatol Ther, 2017,30（6）doi: 10.1111/dth.12561. |
| ［101］ | O′Brien DP, Jenkin G, Buntine J, et al. Treatment and prevention of Mycobacterium ulcerans infection （Buruli ulcer） in Australia: guideline update［J］. Med J Aust, 2014,200（5）:267⁃270. doi: 10.5694/mja13.11331. |
| ［102］ | Junghanss T, Um Boock A, Vogel M, et al. Phase change material for thermotherapy of Buruli ulcer: a prospective observational single centre proof⁃of⁃principle trial［J/OL］. PLoS Negl Trop Dis, 2009,3（2）:e380. doi: 10.1371/journal.pntd. 0000380. |
| ［103］ | Tyner HL, Wilson JW. Fifteen⁃year clinical experience with Mycobacterium haemophilum at the Mayo Clinic: a case series［J］. J Clin Tuberc Other Mycobact Dis, 2017,8:26⁃32. doi: 10.1016/j.jctube.2017.06.002. |
| ［104］ | Nookeu P, Angkasekwinai N, Foongladda S, et al. Clinical characteristics and treatment outcomes for patients infected with Mycobacterium haemophilum［J］. Emerg Infect Dis, 2019,25（9）:1648⁃1652. doi: 10.3201/eid2509.190430. |
| ［105］ | Harris GD, Johanson WG, Nicholson DP. Response to chemotherapy of pulmonary infection due to Mycobacterium kansasii［J］. Am Rev Respir Dis, 1975,112（1）:31⁃36. doi: 10.1164/arrd.1975.112.1.31. |
| ［106］ | Johnston JC, Chiang L, Elwood K. Mycobacterium kansasii［J］. Microbiol Spectr, 2017,5（1）:TNMI7⁃0011⁃2016. doi: 10.1128/microbiolspec.TNMI7⁃0011⁃2016. |
| ［107］ | Sun Z, Zhang Y. Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide［J］. Antimicrob Agents Chemother, 1999,43（3）:537⁃542. doi: 10.1128/AAC.43.3.537. |
| ［108］ | Nessar R, Cambau E, Reyrat JM, et al. Mycobacterium abscessus: a new antibiotic nightmare［J］. J Antimicrob Chemother, 2012,67（4）:810⁃818. doi: 10.1093/jac/dkr578. |
| ［109］ | Philips RC, Hoyer PE, White SM, et al. Cutaneous nontuberculous mycobacteria infections: a retrospective case series of 78 patients from the Texas Gulf Coast region［J］. J Am Acad Dermatol, 2019,81（3）:730⁃739. doi: 10.1016/j.jaad.2019.04.022. |
| ［110］ | Ma Q, Chen R, Yang E, et al. Non⁃tuberculous mycobacterial infection of the musculoskeletal system detected at two tertiary medical centres in Henan, China, 2016-2020［J］. Front Microbiol, 2021,12:791918. doi: 10.3389/fmicb.2021. 791918. |
| ［111］ | Brown⁃Elliott BA, Woods GL. Antimycobacterial susceptibility testing of nontuberculous mycobacteria［J］. J Clin Microbiol, 2019,57（10）:e00834⁃00819. doi: 10.1128/JCM.00834⁃19. |
| ［112］ | 顾有守. 皮肤非结核分枝杆菌病及其治疗［J］. 皮肤性病诊疗学杂志, 2015（3）:163⁃165. doi: 10.3969/j.issn.1674⁃8468. 2015.03.002. |
| ［113］ | Gong N, Tan Y, Li M, et al. ALA⁃PDT combined with antibiotics for the treatment of multiple skin abscesses caused by Mycobacterium fortuitum［J］. Photodiagnosis Photodyn Ther, 2016,15:70⁃72. doi: 10.1016/j.pdpdt.2016.05.009. |
| [1] | 中华医学会皮肤性病学分会 中国医师协会皮肤科医师分会 中国中西医结合学会皮肤性病专业委员会 . [开放获取] 中国化学剥脱术临床应用专家共识（公众版2024版）[J]. 中华皮肤科杂志, 2024, 0(5): 20230620-e20230620. |
| [2] | 宋雨晴 杨楠 刘琳琳 冯子仪 韩世新 周梅娟. [开放获取] 皮肤磨削术治疗家族性良性慢性天疱疮6例临床观察[J]. 中华皮肤科杂志, 2024, 0(4): 20220278-e20220278. |
| [3] | 洪永镇 王倩 梁俊琴. 二代测序技术在非遗传性皮肤病领域中的运用[J]. 中华皮肤科杂志, 2024, 0(3): 20220436-e20220436. |
| [4] | 王煜坤 刘洁. 深度学习在非肿瘤性皮肤病中的应用进展[J]. 中华皮肤科杂志, 2024, 0(3): 20220660-e20220660. |
| [5] | 陈星宇 姚煦. 中性粒细胞在炎症性皮肤病中的研究进展[J]. 中华皮肤科杂志, 2024, 0(3): 20220865-e20220865. |
| [6] | 陈立新 王莹 高西波 秦蓓 李钦峰. 儿童经典型和色素减退型扁平疣反射式共聚焦显微镜特征及与组织病理的对应关系初探[J]. 中华皮肤科杂志, 2024, 0(2): 20220419-e20220419. |
| [7] | 中国医师协会皮肤科医师分会 中华医学会皮肤性病学分会 中国医疗保健国际交流促进会皮肤医学分会 疑难重症及罕见病国家重点实验室 国家皮肤与免疫疾病临床医学研究中心. 特应性皮炎治疗药物应用管理专家共识（2024版）[J]. 中华皮肤科杂志, 2024, 57(2): 97-108. |
| [8] | 李吉 谢红付. 如何避免玫瑰痤疮的误诊[J]. 中华皮肤科杂志, 2024, 57(2): 119-122. |
| [9] | 那君 李若瑜 仲少敏 杨莉 吴艳. 玫瑰痤疮真实世界诊疗现状调查分析[J]. 中华皮肤科杂志, 2024, 57(2): 127-133. |
| [10] | 郭蕾 曹春艳 方晓雅 冯素英. 自身免疫性大疱病患者创面感染多重耐药菌现况及危险因素分析[J]. 中华皮肤科杂志, 2024, 57(2): 155-160. |
| [11] | STAR皮肤科学专科委员会. 2022年医学期刊发表中国皮肤病学指南和共识的科学性、透明性和适用性评级[J]. 中华皮肤科杂志, 2024, 57(2): 141-146. |
| [12] | 王诗琪 王爱平 李航 李若瑜. 趾甲银屑病与指甲银屑病的皮肤镜特征比较[J]. 中华皮肤科杂志, 2024, 57(2): 161-165. |
| [13] | 闫娜 陈婷 耿松梅 李政霄 刘燕 马迎新 谭宣丰. 皮下非对称减张联合真皮埋没成角褥式缝合在婴幼儿面部良性色素性皮损手术治疗中的应用[J]. 中华皮肤科杂志, 2024, 57(1): 54-57. |
| [14] | 中国中西医结合学会皮肤性病专业委员会皮肤肿瘤学组 中国抗癌协会黑色素瘤专业委员会. [开放获取] 人干扰素α1b治疗黑色素瘤专家共识（2024版）[J]. 中华皮肤科杂志, 2024, 57(1): 1-7. |
| [15] | 陈慧 李冰 李春英 郭伟楠. 水刀磨削或电动磨削联合负压吸疱自体表皮移植术治疗白癜风的疗效比较[J]. 中华皮肤科杂志, 2024, 57(1): 43-45. |
|
